The Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jyotishna Sunil Chari
ROSSARI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.9 pts more than Nifty Microcap 250 and 1.4 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
BSE has received a disclosure under Regulation 29(1) & 29(2) of SEBI's Substantial Acquisition of Shares & Takeovers Regulations, 2011 from Jyotishna Sunil Chari. These regulations require any person holding 5% or more of a company's shares to report every change in their shareholding—either acquisitions or disposals—once the 5% threshold is crossed. The announcement confirms that a disclosure form has been filed but the headline does not specify whether this was a purchase or sale, the number of shares involved, or the resulting shareholding percentage. Investors would need to check the full disclosure on the BSE website for the actual transaction details.
The market impact depends entirely on whether the disclosure is a buy or sell and the size of the change. Without these details in the announcement itself, investors should review the full disclosure to assess any potential shift in promoter or major shareholder stake in Rossari Biotech.